Acute myeloid leukemia in adults aged 18 to 60

1 total trials

Filter these 1 trials by phase, country, sponsor and more.

Open in Search →

Phase 3 trial aimed at improving the overall survival of AML in adults aged 18 to 60 by comparing high-dose idarubicin with daunorubicin at … Recruitment ended

2024-516873-57-00 10 2026-01-13

Showing 1–1 of 1 trials